We are live on ! Find out more
CYTK icon

Cytokinetics
CYTK

122 hedge funds and large institutions have $380M invested in Cytokinetics in 2018 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 46 increasing their positions, 34 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

35% more repeat investments, than reductions

Existing positions increased: 46 | Existing positions reduced: 34

22% more capital invested

Capital invested by funds: $311M → $380M (+$69.1M)

1.52% more ownership

Funds ownership: 69.19% → 70.71% (+1.5%)

5% more call options, than puts

Call options by funds: $917K | Put options by funds: $875K

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

3% less funds holding

Funds holding: 126 → 122 (-4)

18% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 17

Holders
122
Holders Change
-4
Holders Change %
-3.17%
% of All Funds
2.79%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
14
Increased
46
Reduced
34
Closed
17
Calls
$917K
Puts
$875K
Net Calls
+$42K
Net Calls Change
+$182K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$6.05M
2
GPP
Great Point Partners
Connecticut
+$5.9M
3
Invesco
Invesco
Georgia
+$2.84M
4
SDIC
South Dakota Investment Council
South Dakota
+$1.46M
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$1.29M

Top Sellers

Rank Fund Capital Flow
1
BI
BVF Inc
California
-$2.92M
2
Millennium Management
Millennium Management
New York
-$1.87M
3
Goldman Sachs
Goldman Sachs
New York
-$1.13M
4
Allianz Asset Management
Allianz Asset Management
Germany
-$952K
5
PA
Pinnacle Associates
New York
-$875K
Name Holding Trade Value Shares
Change 		Change in
Stake
SAM
76
Sectoral Asset Management
Quebec, Canada
$153K +$125K +15,582 New
MLICM
77
Metropolitan Life Insurance Company (MetLife)
New York
$135K – – –
Man Group
78
Man Group
United Kingdom
$132K -$39.3K -4,900 -27%
COPPSERS
79
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$128K +$18.2K +2,264 +21%
HighTower Advisors
80
HighTower Advisors
Illinois
$125K +$102K +12,700 New
PIA
81
Piedmont Investment Advisors
North Carolina
$123K +$5.27K +657 +6%
VF
82
Virtu Financial
New York
$111K +$90.4K +11,271 New
JG
83
Jefferies Group
New York
$110K +$89.9K +11,200 New
Bank of America
84
Bank of America
North Carolina
$106K -$139K -17,294 -62%
TRSOTSOK
85
Teachers Retirement System of the State of Kentucky
Kentucky
$105K – – –
JP Morgan Chase
86
JP Morgan Chase
New York
$105K +$10.5K +1,314 +14%
Squarepoint
87
Squarepoint
New York
$100K +$81.5K +10,162 New
PA
88
Profund Advisors
Maryland
$99K -$7.75K -966 -9%
BC
89
Birchview Capital
Vermont
$99K – – –
LTFS
90
Ladenburg Thalmann Financial Services
Florida
$95K +$46K +5,736 +144%
PNC Financial Services Group
91
PNC Financial Services Group
Pennsylvania
$68K +$1.22K +152 +2%
UBS Group
92
UBS Group
Switzerland
$68K +$43.1K +5,377 +344%
FCM
93
Flinton Capital Management
Pennsylvania
$66K +$25.4K +3,162 +89%
TAM
94
Tyers Asset Management
Texas
$55K +$20.9K +2,604 +89%
RCM
95
Riverhead Capital Management
Delaware
$48K +$18.5K +2,300 +88%
NA
96
Neuburgh Advisers
California
$43K +$16.4K +2,046 +89%
AIP
97
Ameritas Investment Partners
Nebraska
$36K – – –
Royal Bank of Canada
98
Royal Bank of Canada
Ontario, Canada
$32K +$21.3K +2,654 +487%
MCIM
99
Meadow Creek Investment Management
Georgia
$31K +$11.9K +1,488 +89%
Pacer Advisors
100
Pacer Advisors
Pennsylvania
$26K +$21.2K +2,648 New
2 3
4
5 6

CYTK Hedge Fund Activity: Q3 2018 in Review

122 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Cytokinetics (CYTK) for Q3 2018, worth a combined $380M — up 22% from $311M a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of CYTK and 14 opened new positions — a net loss of 3 holders — while 34 trimmed existing stakes and 46 added.

The largest buyer was BlackRock, adding an estimated $6.05M. The largest seller was BVF Inc, cutting an estimated $2.92M.

  • 122 institutional investors held Cytokinetics (CYTK) as of Q3 2018, down from 126 in Q2 2018.
  • Funds reported $380M of Cytokinetics stock for Q3 2018, up 22% quarter-over-quarter.
  • 14 funds opened new Cytokinetics positions in Q3 2018 and 17 closed out, a net change of -3 holders.
  • The largest Cytokinetics buyer in Q3 2018 was BlackRock, an estimated $6.05M added.
  • The largest Cytokinetics seller in Q3 2018 was BVF Inc, an estimated $2.92M sold.

Based on aggregated 13F filings for Q3 2018.